4//SEC Filing
Mazumdar Claire 4
Accession 0002034671-25-000012
CIK 0002023658other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:02 PM ET
Size
6.8 KB
Accession
0002034671-25-000012
Insider Transaction Report
Form 4
Mazumdar Claire
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-16$5.45/sh+29,500$160,884→ 339,392 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-16−29,500→ 565,512 totalExercise: $5.45Exp: 2033-12-14→ Common Stock (29,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in sixteen equal quarterly installments following December 14, 2023, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Bicara Therapeutics Inc.
CIK 0002023658
Entity typeother
Related Parties
1- filerCIK 0002034671
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:02 PM ET
- Size
- 6.8 KB